Lysophosphatidylcholine modulates cardiac I(Na) via multiple protein kinase pathways

Circulation Research

Volumn 81, Issue 3, 1997, Pages 387-395

  Watson, Cheryl L ^a   Gold, Michael R ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Cardiac Na+ current; Lysopbosphatidylcholine; Protein kinase C; Protein tyrosine kinase

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PROTEIN KINASE C;

ANIMAL CELL; ARRHYTHMOGENESIS; ARTICLE; CELL MEMBRANE DEPOLARIZATION; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HYDROLYSIS; LIPID BILAYER; LIPID METABOLISM; NONHUMAN; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; RAT; SODIUM CURRENT; TISSUE SPECIFICITY;

EID: 0030843576     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.3.387     Document Type: Article

References (54)

1. Creer MH, Dobmeyer DJ, Corr PB. Amphipathic lipid metabolites and arrhythmias during myocardial ischemia. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology From Cell to Bedside. Philadelphia, Pa: WB Saunders; 1990; pp 417-433.
2. Oishi K, Raynor RL, Charp PA, Kuo JF, Regulation of protein C by lysophospholipids. J Biol Chem. 1988;263:6365-6871.
3. Liscovitch M, Cantley LC. Lipid second messengers. Cell. 1994;77: 329-334.
4. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995;9:484-496.
5. Sasaki Y, Asaoka Y, Nishizuka Y. Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids: sub-species differences. FEBS Lett. 1993;320:47-51.
6. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidylcholine increases vascular Superoxide anion production via protein kinase C activation. Arterioscler Thromb. 1994;14: 1007-1013.
7. Sugiyama S, Kugiyama K, Ohgushi M, Fujimoto K, Yasue H. Lysophosphatidylcholine in oxidized low-density lipoptotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: role of protein C. Circ Res. 1994;74:565-575.
8. Corr PB, Cain ME, Witkowski FX, Price DA, Sobel BE. Potential arrhythmogenic electrophysiological derangements in canine Purkinje fibers induced by lysophosphoglycerides. Circ Res. 1979; 44:822-832.
9. Synder DW, Crafford WA Jr, Glashow JL, Rankin D, Sobel BE, Coor PB. Lysophosphoglycerides in ischemic myocardium effluent and potentiation of their arrhythmogenic effects. Am J Physiol. 1981;241:H700-H707.
10. Corr PB, Snyder DW, Cain ME, Crafford WA, Gross RW, Sobel BE. Electrophystological effects of amphiphiles on canine Purkinje fibers: implications for dysrhythmia secondary to ischemia. Circ Res. 1981;49:354-363.
11. Saw T, Kiyosue T, Arita M. Inhibitory effects of patmitoylcarnitine and lysophosphatidylcholine on the sodium current of cardiac ventricular cells. Pflugers Arch. 1992;420:94-100.
12. Undrovinas AI, Fleidervish IA, Makielski JC. Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res. 1992;71: 1231-1241.
13. Shander GS, Undrovinas AI, Makielski JC. Rapid onset of lysophosphatidylcholine-induced modification of whole cell cardiac sodium current. J Mol Cell Cardiol. 1996;28:743-753.
14. Burnashev NA, Undrovinas AI, Fleidervish IA, Makielski JC, Rosenshtraukh LV. Modulation of cardiac sodium channel gating by lysophosphatidylcholine. J Mol Cell Cardiol. 1991;23(suppl I): I-23-I-30.
15. Lundaek JA, Andersen OS. Lysophospholipids modulate channel function by altertag the mechanical properties of lipid bilayer J Gen Physiol. 1994;104:645-673.
16. Engelman GL, McTiernan C, Gerrity RG, Samarel AM. Serum-free primary cultures of neonatal rat cardiomyocytes cellular and molecular applications. Technique. 1990;2:279-291.
17. Hanck DA, Sheets MF. Extracellular divalent and trivalent cation effects on sodium current kinetics in single canine cardiac Purkinje cells. J Physiol (Lond). 1992;454:267-298.
18. Vassort G, Alvarex J. Cardiac t-type calcium current: pharmacology and roles in cardiac tissues. J Cardiovasc Electrophysiol. 1994;5: 376-393.
19. Gold MR, Strichartz GR. Use-dependent block of atrial sodium current by ethylisopropylamiloride. J Cardiovasc Electrophysiol 1991;17:792-799.
20. Fozzard HA, January CT, Makielski JC. New studies of the excitatory sodium currents in heart muscle. Circ Res. 1985;56:475-485.
21. + current in single canine cardiac Purkinje cells. Am J Physiol. 1992; 262:H1197-H1207.
22. Goldman L, Sodium channel inactivation from closed states; evidence for an intrinsic voltage dependency. Biophys J. 1995;69: 2369-2377.
23. Lawrence JH, Yue DT, Rose WC, Marban E. Sodium channel inactivation from resting states in guinea-pig ventricular myocytes. J Physiol (Lond). 1991;443:629-650.
24. Watson CL, Gold MR. The effect of intracellular and extracellular acidosis on the sodium current in ventricular myocytcs. Am J Physiol. 1995;268:H1749-H1756.
25. House C, Robinson PJ, Kemp BE. A synthetic peptide analog of the putative substrate-binding motif activates protein kinase C. Fed Eur Biochem Sci Lett. 1989;249:243-247.
26. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993-999.
27. Tsuda T, Kawahara Y, Shii K, Koide M, Ishida Y, Yokoyama M. Vasoconstriction-induced protein tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett. 1991;285:44-48.
28. Huang XY, Morielli AD, Peralta EG. Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor. Cell. 1993;75:1145-1156.
29. 2+-induced regulation of ion channel and MAP kinase functions. Nature. 1995;376:737-745.
30. Rudd CE, Janssen O, Prasad KVS, Raab M, da Silva A, Telfer JC, Yamamoto M. src-related protein tyrosine kineses and their surface receptors. Biochim Biophys Acta. 1993;1155:239-266.
31. Quartes LD, Haupt DM, Davidai G, Middleton JP. Prostaglandin F2a-induced mitogenesis in MC3T3-E1 osteoblasts: role of protein kinase C-mediated tyrosine phosphorylation. Endocrinology. 1993; 132:1505-1513.
32. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S-I, Itoh N, Shibuya M, Fukamai Y, Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987;262:5592-5595.
33. McHowat J, Yamada KA, Wu J, Yan GX, Corr PB. Recent insights pertaining to sarcolemmal phospholipid alterations underlying arrhythmogenesis in the ischemic heart. J Cardiovasc Electrophysiol. 1993;4:288-310.
34. Arnsdorf MF, Sawicki GJ. The effects of lysophosphatidylcholine, a toxic metabolite of ischemia, on the components of cardiac excitability in sheep Purkinje fibers. Circ Res. 1981;49:16-30.
35. Epand RM, Lester DS. The role of membrane biophysical properties in the regulation of protein kinase C activity. Trends Pharmacol Sci. 1990;11:317-320.
36. Man RYK, Kinnaird AAA, Bihler I, Choy PC. The association of lysophosphatidylcholine with isolated cardiac myocytes. Lipids. 1990;25:450-454.
37. Puceat M, Hilal-Dandan R, Strulovici B, Brunton LL, Brown JH. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem. 1994;269: 16938-16944.
38. VanWinkle WB, Snuggs M, Buja LM. Hypoxia-induced alterations in cytoskeleton coincide with collagenase expression in cultured neonatal rat cardiomyocytes. J Mol Cell Cardiol. 1995;27:2531-2542.
39. Kugiyama K, Ohgushi M, Sugiyama S, Murohara T, Fukunaga K, Miyamoto E, Yasue H. Lysophosphatidylcholine inhibits surface receptor- mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 1992;71: 1422-1428.
40. Marquardt DL, Walker LL. Lysophosphatidylcholine induces mast cell secretion and protein kinase C activation. J Allergy Clin Immunol. 1991;88:721-730.
41. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258;607-614.
42. Ahmed S, Kozma R, Monfries C, Hall C, Lim HH, Smith P, Lim L. Human brain η-chimaerin cDNA encodes a novel phorbol ester receptor. Biochem J. 1992;272:767-773.
43. Liscovitch M. Crosstalk among multiple signal-activated phospholipases. Trends Biochem Sci. 1992;17:393-398.
44. Billah MM, Anthes JC. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J. 1990;269:281-291.
45. Kiss Z, Anderson WB. Phorbol ester stimulates the hydrolysis of phosphatidylethanolamine in leukemic HL-60. NIH 3T3, and baby hamper kidney cells. J Biol Chem. 1989;264:1483-1487.
46. Cukierman S. Regulation of voltage-dependent sodium channels. J Membr Biol. 1996;151:203-214.
47. + current inactivation by stimulation of protein kinase C in cardiac cells. Circ Res. 1997; 81:380-386.
48. Catterall WA. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev. 1992;72(suppl):S15-S48.
49. Undrovinas AI, Shander GS, Makielski JC. Cytoskeleton modulates gating of voltage-dependent sodium channel in heart. Am J Physiol. 1995;269:H203-H214.
50. Holmes TC, Fadool DA, Ren R, Levitan IB. Association of src tyrosine with a human potassium channel mediated by SH3 domain. Science. 1996;274:2089-2091.
51. Hille B. Ionic Channels of Excitable Membranes. Sunderland, Mass: Sinauer Associates; 1992.
52. Kozawa O, Suzuki A, Oiso Y, Tyrosine kinase regulates phospholipase D activation at a point downstream from protein kinase C in osteoblast-like cells. J Cell Biochem. 1995;57:251-255.
53. 2+ accumulation in rat cardiac myocytes. Am J Physiol. 1983;244:H32-H38.
54. 2+-overload in isolated cardiomyocytes and effect of cytoprotective drugs. J Mol Cell Cardiol. 1992;24;977-988.